Protective effect of Guanxinning on antipsychotic-induced cardiac impairment in long-term hospitalized psychiatric patients

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Psychiatry. Jan 19, 2026; 16(1): 111840
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.111840

Table 7 Friedman test results (within group comparison)

Group	χ² value	P value
Guanxinning intervention group	187.5	< 0.001
Control group	24.3	< 0.001

Citation: Luo FG, Xing HY, Wang JJ, Wu WY, Fang KJ, Song HD, Yan J. Protective effect of Guanxinning on antipsychotic-induced cardiac impairment in long-term hospitalized psychiatric patients. World J Psychiatry 2026; 16(1): 111840
URL: https://www.wjgnet.com/2220-3206/full/v16/i1/111840.htm
DOI: https://dx.doi.org/10.5498/wjp.v16.i1.111840

Luo FG, Xing HY, Wang JJ, Wu WY, Fang KJ, Song HD, Yan J. Protective effect of Guanxinning on antipsychotic-induced cardiac impairment in long-term hospitalized psychiatric patients. World J Psychiatry 2026; 16(1): 111840 [PMID: 41607441 DOI: 10.5498/wjp.v16.i1.111840]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.